Category: Fox News
‘Place your left hand on the Quran’: Foreign-born lieutenant governor does not swear in on Bible
In one of the clearest examples of elections having consequences in recent times, Virginia’s new lieutenant governor’s swearing-in ceremony made history for its unorthodox changes.
On Saturday, Ghazala Firdous Hashmi took her oath of office to fill the lieutenant governor seat. However there was one major twist to the proceedings: Instead of placing her left hand on the Bible, Hashmi swore her oath on the Quran.
Hashmi sees her election and inauguration as a sign of Virginia’s ‘continued progress toward a more representative and inclusive democracy.’
“Place your left hand on the Quran,” the woman directing the inauguration instructed Hashmi.
“I, Ghazala Firdous Hashmi, do solemnly swear that I will support the Constitution of the United States,” she said during the ceremony.
RELATED: Progressive wins VA race despite admitted indifference to ‘sexually explicit material’ in schools
Photo by Win McNamee/Getty Images
According to her official website, Hashmi was born in Hyderabad, India, and was brought to the United States as a child.
She is the first Muslim woman to hold statewide office in the nation and the first South Asian-American to be elected to statewide office in Virginia.
Hashmi sees her election and inauguration as a sign of Virginia’s “continued progress toward a more representative and inclusive democracy.”
Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!
Top GOP senator says Syria ceasefire welcome but actions must match words
Syria reaches fragile ceasefire with Kurdish forces as U.S. senator warns about reported crimes by government troops during military operation against SDF.
Don Lemon put ‘on notice’ by DOJ for role in covering protest that stormed church
DOJ official Harmeet Dhillon said journalist Don Lemon is “on notice” for his role in monitoring a protest that stormed a church in Minneapolis.
Bills defensive lineman calls Sean McDermott’s firing ‘sickening’
Buffalo Bills defensive tackle Jordan Phillips appeared to be upset with the team’s decision to fire head coach Sean McDermott on Monday.
UFO task force eyed as lawmaker warns of strange objects in skies and waters defying known technology
Vermont UFO task force proposed by Rep. Troy Headrick would investigate unidentified anomalous phenomena reports and assess airspace safety risks in coordination with federal partners.
White House says Walz, Frey incited chaos after anti-ICE mob storms Minneapolis church
Minneapolis faces escalating anti-ICE protests following fatal shooting of protester Renee Good, with federal agents investigating church disruption and fraud scandal.
Elon Musk pours a staggering $10M into Kentucky Senate race, backing pro-Trump business outsider
Pro-Trump outsider Nate Morris says Musk’s staggering donation gives his Kentucky Senate campaign firepower to compete against establishment Republicans.
Only Government Force Can Stop Democrats From Plunging America Into Darkness
Democrats created the situation America finds itself in, and only a forceful crackdown on leftist anarchy will restore cultural stability.
Ozempic no replacement for willpower when it comes to weight loss
A new meta-study — a study of studies — reveals an inconvenient truth about weight loss itself: Willpower still matters. Manufacturers of GLP-1 injectables like Wegovy and Ozempic would prefer we forget that, since forgetting it is profitable.
The counter-claim — that diets and exercise are no match for our genes and environment — is one fat-positivity influencers have pushed for years. Now it has been eagerly adopted by companies like Novo Nordisk and Eli Lilly to market their new, lizard-venom-derived blockbuster drugs.
People who stop taking weight-loss drugs regain weight at an average rate of 0.4 kilograms per month — roughly 10 pounds per year.
Business is booming. One in eight American adults have taken a weight-loss drug at one time — and this is only the beginning. Uptake remains far below its theoretical ceiling: More than 70% of U.S. adults are overweight or obese, including roughly 40% who are clinically obese.
Shred-pilled?
What comes next is obvious. Adoption will surge as delivery methods improve, especially pills. People don’t like needles. Pills are much easier to swallow.
Just before Christmas, the Food and Drug Administration approved a pill version of Wegovy, imaginatively branded the Wegovy Pill. Pill versions of competing drugs, including Mounjaro, are expected to follow this year.
Some time ago, I predicted that a weight-loss drugmaker would become the largest company in the world within a decade. I made that prediction when Novo Nordisk — the Danish maker of Wegovy and Ozempic — became Europe’s most valuable company, with a market capitalization of roughly $570 billion, more than $200 billion greater than Denmark’s entire GDP. (It has since fallen a few spots.) I now refine that forecast: The pharmaceutical company that perfects the weight-loss pill — balancing results, side effects, and cost — will be the largest company on Earth.
There are already more than one billion obese people worldwide. There is no obvious reason why every one of them couldn’t be prescribed a daily pill.
RELATED: Fat chance! Obese immigrants make America sicker
Gilles Mingasson/Getty Images
Chubby checkers
Which brings us back to the meta-study. One of the central unanswered questions surrounding these drugs is what happens when patients stop taking them. Does the weight stay off — or does it return?
In practice, many people don’t stay on them long. Roughly half of users discontinue weight-loss drugs within a year, most often citing cost and side effects, which can include severe gastrointestinal distress, vision problems, and — in rare cases — death.
What happens after discontinuation matters enormously. If the weight returns, many users will be forced to remain on these drugs indefinitely — possibly for decades — to avoid relapse. Pharmaceutical executives have generally been reluctant to acknowledge this implication, though some have done so candidly.
Habit-forming
The researchers behind the new meta-study asked a sharper question still: How does stopping weight-loss drugs compare with stopping traditional interventions like diet and exercise?
The answer is stark. People who stop taking weight-loss drugs regain weight at an average rate of 0.4 kilograms per month — roughly 10 pounds per year. That is four times faster than the weight regain seen in people who stop exercising and restricting calories.
Four times.
The explanation is not mysterious. Pills do not build habits. Diet and exercise do. With drugs, appetite suppression is outsourced to chemistry rather than cultivated through discipline. Remove the compound, and users are left with the same reserves of willpower they had before. Evidence so far suggests that changes to brain chemistry, hormone signaling, and metabolism fade along with the drug itself.
Even when people who diet and exercise relapse, the habits they developed tend to soften the fall. That counts for something.
None of this is to deny that weight-loss drugs can be a valuable tool. For many severely obese people, they may represent the only realistic chance of meaningful weight reduction. If we want to reduce the burden of chronic disease, drugs like Wegovy will have a role to play.
But their rise should not excuse the abandonment of harder truths. Sustainable weight loss still depends on choices, habits, and character — and on reshaping a food environment that makes bad choices effortless and good ones rare. Pharmaceuticals may assist that work. They cannot replace it.
Portland DA cracks down on drug crimes as Seattle pulls back on enforcement
Portland DA announces drug prosecution crackdown for those refusing treatment, contrasting sharply with Seattle’s lenient approach to possession cases.
